Table of Contents
<< Previous Issue | Sep 2014 (Vol: 2014, Issue: 9) | Next Issue >> |
- Section: Distribution & Marketing
-
MannKind Finally Finds a Partner for its Inhaled Insulin Afrezza® in Sanofi
- Section: Mergers & Acquisitions
-
Abbott Sells Developed Markets Branded Generics Business to Mylan in Spinversion
-
Meda Asserts Independence with US$3.1 B Rottapharm Acquisition
-
AstraZeneca Boosts Respiratory Business with US$2.1 B Almirall Deal
-
Roche to Buy InterMune for US$8.3 B to Gain Pirfenidone for Idiopathic Pulmonary Fibrosis
- Section: Opinion & Analysis
-
IMS PHARMADEALS HALF-YEAR REVIEW 2014